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Background-—Myocardial infarction exhibits seasonal patterning, with higher amplitude at increased latitude. Epidemiological
evidence suggests that sunlight is protective against cardiovascular disease, independent of ambient temperature, but ultraviolet
B–mediated vitamin D production has been discounted as causal. We aimed to determine whether ultraviolet A is associated with
the seasonal patterning of myocardial infarction.
Methods and Results-—Routine hospitalization data were used to determine monthly incidence of myocardial infarction in
Scotland between 2000 and 2011. Small-area–level aggregated data were obtained on ambient temperature from the
Meteorological Office and ultraviolet A and ultraviolet B irradiance from NASA satellites. Autoregressive distributed lag models
were run for ultraviolet A and myocardial infarction, including adjustment for ambient temperature and ultraviolet B. Monthly
incidence of myocardial infarction displayed winter peaks and summer troughs superimposed on the underlying trend, with a mean
amplitude of 0.31 (95% CI: 0.21, 0.41) myocardial infarctions per 100 000 population per month. Ultraviolet A exposure was
inversely associated with myocardial infarction independent of ambient temperature (coefficient, 0.05; 95% CI, 0.09, 0.01;
P=0.015) and ultraviolet B UVB (coefficient, 0.05; 95% CI, 0.09, 0.02; P=0.004).
Conclusions-—Further research is required to explore whether an ultraviolet-mediated mechanism different to vitamin D, such as
nitric oxide–mediated vasodilatation, may play a causal role in the seasonal and geographical patterning of myocardial infarction.
( J Am Heart Assoc. 2019;8:e012551. DOI: 10.1161/JAHA.119.012551.)
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C ardiovascular disease incidence and mortality demon-strate seasonal patterning, with winter peaks in both
hemispheres and higher amplitude further from the equator.1–3
Earlier studies focused on ambient temperature, which may
act directly on cardiovascular physiology or biomarkers or be
mediated by seasonal patterning of lifestyle.1,4–6 However,
other environmental exposures, such as solar radiation, may
also play a role. A number of studies have demonstrated
associations between solar radiation and cardiovascular
disease. In a Swedish cohort, patients with malignant
melanoma who avoided sun exposure had significantly
reduced life expectancy, explained largely by their increased
risk of cardiovascular disease.7 Similarly, a Danish case-
control study reported that both melanoma and nonmelanoma
skin cancers were associated with reduced risk of myocardial
infarction.8 Finally, a Swedish general population cohort study
demonstrated an inverse linear relationship between sun-
exposure score and incidence of myocardial infarction, with
the effect size associated with low sun exposure comparable
with that of smoking.9
Sunlight contains a spectrum of wavelengths, including
ultraviolet (UV) radiation. UV levels are strongly correlated
with season and therefore with other seasonally patterned
exposures, such as ambient temperature. However, superim-
posed on the annual cycle in UV radiation, there is an 11-year
solar cycle over which the number of sunspots changes with
the sun’s oscillatory magnetic field. As a result, UV levels vary
between years. Hence, associations with UV radiation can be
disentangled from associations with other seasonally pat-
terned phenomena, such as ambient temperature. Further-
more, while ultraviolet A (UVA) radiation covers longer
wavelengths (321–400 nm) and is not absorbed by the
ozone layer, ultraviolet B (UVB) covers shorter wavelengths
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(280–315 nm) and therefore is mostly absorbed before
reaching the earth’s surface.10 The actual amount of UVB
reaching the earth’s surface varies greatly with weather
conditions, such as cloud cover.11 Therefore, while levels of
UVA and UVB are correlated, there is sufficient variation to
determine whether associations with UV radiation are driven
by UVA or UVB.
UVA penetrates the skin more deeply than UVB, and they
produce different biological and physiological responses.12 To
date, studies on cardiovascular disease have focused on the
possible role of UVB in promoting production of vitamin D.
However, Mendelian randomization studies and clinical trials
refute a causal role for vitamin D.13–16 Therefore, the aim of
this study was to determine whether UVA was associated with
the seasonal patterning of acute myocardial infarction inde-
pendent of ambient temperature and UVB.
Methods
The study involved secondary analysis of a data set for which
the authors are not the data custodians. Because of the
sensitive nature of the data used in this study, requests to
access the data set from qualified researchers trained in
information governance may be sent to eDRIS (Electronic
Data Research and Innovation Service) at NSS.EDRIS@nhs.-
net. The East of Scotland Research Ethics Service (REC
reference 16/ES/0112; IRAS project ID 206758) provided
National Health Service ethics approval for eDRIS linked data
linkage projects involving secondary use of anonymized data
extracts without written consent, and approval for this study
was granted by the Public Benefit and Privacy Panel (reference
1617-0056).
Data Sources, Inclusion Criteria, and Definitions
We used the Scottish Morbidity Record 01 (SMR01) database
for the period 1990–2011 inclusive to ascertain emergency
admissions to hospital for myocardial infarction, defined as an
International Classification of Diseases code 410.X (Interna-
tional Classification of Diseases, Ninth Revision; ICD-9) or
I21.X (International Classification of Diseases, Tenth Revision;
ICD-10) recorded in the principal position. We used retro-
spective record linkage to exclude admissions preceded by a
hospital admission for myocardial infarction in the previous
10 years. Hence, the study cohort comprised incident hos-
pitalized myocardial infarctions between 2000 and 2011
inclusive. Both fatal and nonfatal myocardial infarctions were
included. Mid-year population counts were obtained from the
National Records of Scotland website (https://www.nrscotla
nd.gov.uk/statistics-and-data/statistics/statistics-by-theme/
population/population-estimates/mid-year-population-estima
tes) and linearly interpolated and extrapolated to provide
population counts for each month over the study years. The
data on incident myocardial infarctions and general popula-
tion were used to derive monthly incidence rate per 100 000
population over the study period, standardized to a common
month length using the formula: count9100 000 9 365.25/
129population9days per month.
Mean monthly ambient temperatures for Scotland were
obtained from the Meteorological Office (https://www.metoff
ice.gov.uk/pub/data/weather/uk/climate/datasets/Tmean/
date/Scotland.txt), which has developed models that provide
spatially detailed estimates of past weather patterns at 5-km2
resolution across the country. The project to develop these
models ended in 2011, and we used the latest available data.
Global 5-km UV radiance-irradiance data were produced by
the Japan Aerospace Exploration Agency (JAXA) using mea-
surements from the MODIS (Moderate Resolution Imaging
Spectroradiometer) instrument on board NASA’s aqua and
terra satellites. Downward irradiance values, combining direct
and diffuse radiation on a horizontal plane, for UVA and UVB
were available from the publicly accessible JAXA website
(ftp://apollo.eorc.jaxa.jp/pub/JASMES/Global_05km/) at a
daily resolution from 2000 for each latitude and longitude on
earth. We obtained data relating to the Great Britain bounding
box (48°N to 63°N; 11°W to 4°E). The points were then
interpolated, by inverse weighted distance, to raster images.
The rasters were projected to the OSGB 1936/British
National Grid. Finally, we took the northing and easting
centroids of each postcode unit in Scotland (Ordnance Survey
Clinical Perspective
What Is New?
• Seasonal patterning of myocardial infarction (winter peaks
and summer troughs) suggests an environmental factor.
• Some evidence exists for an association with solar radiation,
but a causal role for ultraviolet B (through vitamin D) has
been discredited.
• Our study showed an association between ultraviolet A
(which impacts on nitric oxide–mediated vasodilatation) and
myocardial infarction that is independent of temperature
and ultraviolet B.
What Are the Clinical Implications?
• Winter peaks in myocardial infarction represent preventable
morbidity and mortality and a preventable burden on health
services.
• Trials should be conducted on whether interventions, such
as phototherapy boxes or supplements, could safely and
effectively reduce winter peaks and thereby overall inci-
dence.
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Code-Point ver 2017.4.0) and used these to extract the UVA
and UVB values for those grid squares covering residential
areas in Scotland. Scotland-wide monthly means were then
calculated resulting in a monthly time series of UVA and UVB
irradiance values measured in W/m2. In order to be consis-
tent with other epidemiological studies, these values were
converted to kJ/m2 by applying the formula: 986 400
(seconds in the day)/1000.
Statistical Analyses
We estimated mean amplitude and peak phase for the data
using cosinor models, allowing for variable annual phase and
amplitude, with 5000 simulations and a burn-in of 1000.
Parameters of the model were adjusted using the correlogram
of the residuals from the fitted model in order to model as
much seasonal variation as possible.
Multicollinearity between UVA, UVB, and temperature was
investigated using Belsley’s method,17 which uses the
concept of condition indices of a matrix to assess whether
collinearity among a set of regressors is likely to have a
deleterious impact on estimated regression coefficients and
standard errors. Simulation studies run by Belsley suggest
that condition indices in the range 5 to 10 represent a weak
dependence among the regressors and indices from 30 to
100 a strong dependency.
In order to explore the short- and long-run associations
between solar radiation and myocardial infarction incidence,
we used the autoregressive distributed lag (ARDL) modeling
methodology of Pesaran et al.18 ARDL uses the econometric
concept of cointegration to separate out short-term associ-
ations among variables, characterized by the inclusion of time
lags in effect and differences, from long-term relationships
which do not involve lags or differences. Using this technique
avoids the problem of “spurious regression” where variables
in a time-series model appear to be highly statistically
significant, when, in fact, they are not. The incorrect
conclusion arises because of the presence of trend in the
data, which is the main driver of the statistical significance. In
addition to separating out the short- and long-term relation-
ships among the variables, the ARDL methodology also
provides an estimate of how quickly the variables return to
their long-run underlying relationship after any event, or
disruption, that may have knocked them off this path. The
readjustment is called the error correction mechanism and is
estimated along with the other regression coefficients in the
model.
To identify an appropriate ARDL, we used an automatic
estimation procedure based on the Bayesian information
criterion. This procedure evaluates a number of models with
different lag lengths for the dependent and independent
variables and selects the model with the lowest Bayesian
information criterion statistic. We included 2 dummy variables
for the implementation of the Scottish smoke-free legislation,
in March 2006, and the introduction of a high-sensitivity
troponin assay for diagnosis of myocardial infarction, in
October 2010, to allow for possible structural breaks in the
series. We then tested the residuals of the best-fitting model
for any remaining serial correlation using Breusch–Godfrey–
Lagrange multiplier tests.
To check model stability over time, we used the recursive
residuals, CUSUM and CUSUMSQ graphical tests. The
underlying model was then subjected to the Bounds testing
procedure of Pesaran et al18 to identify appropriate cointe-
grating relationships and long-run measures of association.
Myocardial infarction incidence, sunshine hours, UVA, and
UVB were logged before modeling, while an inverse hyperbolic
sine transformation was applied to ambient temperature to
mitigate the presence of zero and negative values. We ran 3
sets of models, including: UVA and ambient temperature; UVB
and ambient temperature; and UVA, UVB, and ambient
temperature. Initial data cleaning was done in Stata software
(14.1 MP, StataCorp 2015; StataCorp LP, College Station, TX)
and statistical analyses in MATLAB (The Mathworks, Inc.,
Natick, MA), EViews 10.1 (IHS Global Inc, London, UK), and R
software (version 3.5.1; R Foundation for Statistical Comput-
ing, Vienna, Austria).
Results
Over the 12-year study period, there were 56 370 incident
admissions for myocardial infarction across Scotland. This
equated to a mean annual incidence of 7.60 myocardial
infarctions per 100 000 population. The monthly incidence of
myocardial infarction demonstrated a seasonal pattern, with a
February peak, superimposed on an underlying trend whereby
the incidence fell gently from 2000 to 2009 and then
increased from 2010, coinciding with the introduction of high-
sensitivity troponin assays for the diagnosis of myocardial
infarction (Figure 1). The mean amplitude over the study
period was 0.31 (95% CI, 0.21, 0.41) myocardial infarctions
per 100 000 population per month. UVA, UVB, and ambient
temperature all demonstrated seasonal patterns with summer
peaks (Figure 2A through 2C). Over the study period, the ratio
of UVA to UVB ranged from 49 to 748, with a mean of 135.
The Pearson correlation coefficient between UVA and UVB
was 0.98. However, Belsley’s procedure produced a condition
index of 8.3, implying weak dependence between the
variables. This result suggests that the inclusion of both
variables in a regression model would not result in problems
with multicollinearity.
In the ADRL model, UVA exposure was inversely associated
with incidence of myocardial infarction in the following month,
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independent of ambient temperature (coefficient, 0.05; 95%
CI, 0.09, 0.01; P=0.015) and remained so when UVB was
added to the model (coefficient, 0.05; 95% CI, 0.09,
0.02; P=0.004; Table 1). A coefficient of 0.05 can be
interpreted as a 1% higher ambient temperature being
associated with a 0.05% lower incidence of myocardial
infarction or a 10% higher ambient temperature being
associated with a 0.5% lower incidence. In contrast to UVA,
following adjustment for ambient temperature, the associa-
tion between UVB and myocardial infarction just failed to
reach statistical significance (P=0.067) and became non-
significant when UVA was added to the model (P=0.820). All 3
models were a good fit with adjusted R2 values of 74% to 76%,
and all models passed the test for white-noise residuals
(Figure 3). On subgroup analysis, the independent association
with UVA was observed both aged >60 years (coefficient,
0.06; 95% CI, 0.10, 0.02; P=0.006) and ≤60 years
(coefficient, 0.03; 95% CI, 0.06, 0.00; P=0.040). It was
present in men (coefficient, 0.06; 95% CI, 0.10, 0.02;
P=0.002), but was nonsignificant in women.
The long-run models produced similar results and showed
that the associations were quick to adjust to deviations in
their long-run path, with 42% and 43% of the disruption to
myocardial infarction incidence corrected within 1 month
following changes to UVA and UVB, respectively (Table 2).
When both UVA and UVB were included in the same model,
the speed of adjustment increased to 63%. Graphs of the
CUSUM and CUSUMSQ recursive residuals revealed no
instability in the estimated coefficients in any of the models,
with all coefficient paths within the 95% CI bounds.
Discussion
Myocardial infarction and UVA exhibited opposite seasonal
patterns with winter and summer peaks, respectively. Year-
on-year variations in UVA, over and above these seasonal
patterns, were associated with myocardial infarction inci-
dence independent of both ambient temperature and UVB.
Therefore, we hypothesize that low UVA may be contributing
to both the winter peaks and higher overall incidence of
myocardial infarction in higher-latitude countries.
Studies exploring the associations between solar radiation
and cardiovascular disease have, so far, focused on vitamin D.
Inverse relationships have been demonstrated between 25-
hydroxy vitamin D concentrations and cardiovascular risk
factors and disease,19–21 and because exposure to UVB is the
major source of vitamin D, individuals living in higher-latitude
countries commonly experience vitamin D deficiency over
winter months.21 However, Mendelian randomization studies
do not support a causal link between vitamin D and
cardiovascular disease,13 and vitamin D supplementation
Figure 1. Crude monthly incidence of acute myocardial infarction (AMI) admissions.
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C
Figure 2. Monthly environmental exposure measurements. A, Ultraviolet A irradiance. (B) Ultraviolet B
irradiance. (C) Ambient temperature.
DOI: 10.1161/JAHA.119.012551 Journal of the American Heart Association 5
UVA and MI Seasonality Mackay et al
O
R
IG
IN
A
L
R
E
S
E
A
R
C
H
D
ow
nloaded from
 http://ahajournals.org by on November 27, 2019
studies have not been effective at reducing it.14,15 Therefore,
vitamin D may simply be a marker for solar radiation, which is
acting through another mechanism. Our finding of an
association that was specific to UVA supports this, given
that UVA does not promote vitamin D production. A causal
role for UVA is biologically plausible. UVA mobilizes nitric
oxide in the skin, which then acts on vascular smooth muscle
causing vasodilatation,22 resulting in reduced blood pressure,
Table 1. Autoregressive Distributed Lag Model of the Associations With Incidence of Acute Myocardial Infarction Admissions of
Ultraviolet A and Ultraviolet B
Ultraviolet A Ultraviolet B Ultraviolet A and B
Coefficient* 95% CI P Value Coefficient* 95% CI P Value Coefficient* 95% CI P Value
Fitted ADRL models
Log incidence
(1-mo lag)
0.36 0.22 to 0.49 <0.001 0.36 0.23 to 0.49 <0.001 0.35 0.20 to 0.50 <0.001
Log incidence
(2-mo lag)
0.23 0.07 to 0.39 0.006 0.21 0.06 to 0.36 0.007   
Log ambient
temperature
0.02 0.0002 to 0.0400 0.048 0.02 0.01 to 0.02 0.843 0.01 0.01 to 0.03 0.264
Log UVA 0.01 0.04 to 0.02 0.603    0.01 0.03 to 0.04 0.774
Log UVA (1 mo lag) 0.05 0.09 to 0.01 0.015    0.05 0.09 to 0.02 0.004
Log UVB   0.01 0.03 to 0.001 0.067 0.002 0.02 to 0.02 0.820
Introduction of
smoke-free
legislation
0.06 0.11 to 0.01 0.010 0.06 0.12 to 0.01 0.031 0.04 0.09 to 0.01 0.107
Introduction of
high-sensitivity
troponin assays
0.08 0.02 to 0.13 0.006 0.07 0.02 to 0.12 0.008 0.04 0.02 to 0.10 0.152
Intercept 0.88 0.52 to 1.23 <0.001 0.82 0.47 to 1.17 <0.001 1.30 1.00 to 1.59 <0.001
Regression diagnostics: UVA: adjusted R2, 0.76; F statistic, 46.56; P<0.001; residual Q statistic, P=0.99 at lag 13. UVB: adjusted R2, 0.75; F statistic, 49.36; P<0.001; residual Q statistic,
P=0.99 at lag 13. UVA and UVB: adjusted R2, 0.76; F statistic, 42.78; P<0.001; Residual Q statistic, P=0.50 at lag 13. ARDL indicates autoregressive distributed lag; UVA, ultraviolet A;
UVB, ultraviolet B.
*Percent change in myocardial infarction incidence per unit change in exposure variable (1°C for temperature and 1 kJ/m2 for UVA/B).
Figure 3. Fitted ARDLmodel including UVA, UVB, and ambient temperature. AMI indicates acutemyocardial
infarction; ARDL, autoregressive distributed lag; UVA, ultraviolet A irradiance; UVB, ultraviolet A irradiance.
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increased heart rate, and reduced peripheral resistance,
independent of ambient temperature.23,24 Hypertension is a
major risk factor for cardiovascular disease.25
A strength of this study is the use of unselected, Scotland-
wide data on admissions for myocardial infarction. Cases
were ascertained from routine administrative health data.
However, these undergo regular quality-assurance checks to
ensure high completeness and accuracy. Given that UV could
potentially impact on prognosis as well as occurrence,
retrospective linkage was used to ensure that only incident
cases were included. Over the period studied, accepted
clinical practice was to admit all patients suffering from
myocardial infarction; therefore, the data are likely to be
complete in relation to nonfatal myocardial infarctions.
However, prehospital deaths were not included. Also, we
lacked statistical power to undertake subgroup analyses by
age and sex. Having data over a 12-year period (the maximum
period with both ambient temperature and UV data) provided
sufficient coverage of the solar cycle to distinguish between
associations with solar radiation and other seasonally
patterned phenomena, as well as sufficient variations in
weather to distinguish between associations with UVA and
UVB. A further strength of the study is the use of the ARDL
cointegration methodology to reveal statistically meaningful
long-run relationships in the data, which traditional time-
series regression models ignore. Our use of cointegration
allowed us to conclude that there is a long-run and
statistically significant relationship between acute myocardial
infarction incidence and UV radiation that previous research
has not been able to detect or quantify.
We calculated mean monthly levels of UVA and UVB for
Scotland as a whole. Mainland Scotland measures 441 km
(274 miles) from north to south; this equates to a relatively
small range of latitudes of 0.2° (from 58.4° to 58.6° North).
Our calculation of UV exposure assumed that residents of
Scotland were in Scotland at the time of UV measurement.
This will be the case for measurement contemporaneous with
myocardial infarction. For measurements ≥1 months earlier, a
small proportion of participants may have been on holiday or
work trips aboard. Similarly, we had no data on individual
differences in exposure to UV attributable to the proportion of
time spent outdoors, type of clothing, or use of sunblock.
In conclusion, low exposure to UVA radiation was associated
with winter peaks in myocardial infarction and higher overall
incidence in a higher-latitude country. A causal relationship is
biologically plausible in light of the known effect of UVA
exposure on blood pressure, but further research is needed,
including measures of individual exposure. If corroborated,
consideration should be given to conducting a randomized
controlled trial of UV phototherapy boxes, a relatively inexpen-
sive intervention that could be administered at home.
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